Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
T.GUD
Alternate Symbol(s):
KHTRF
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Apr 01, 2023 1:47pm
RE:Paladin Labs' Revenue Guidance (2007-2012)
Note: If i recall over Paladin's 19 years, there were at least two periods where growth stalled and it took a year to regain the momentum. Now, they have a lot more cash and cash inflow
...more
(6)
•••
curiousj
X
View Profile
View Bullboard History
Comment by
curiousj
on Apr 01, 2023 1:33pm
RE:MUGSY & ALIASES and delusional promotional persistency
gud went public at $3.5
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Apr 01, 2023 12:12pm
MUGSY & ALIASES and delusional promotional persistency
Mugsy $ Aliases ten years and counting and may continue their promotion of GUD but no investors in is going to bail GUS shareholders out. For ten years and nearly one billion in cash at hand GUD has
...more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Post by
gudisgood
on Apr 01, 2023 8:56am
Paladin Labs' Revenue Guidance (2007-2012)
Just went through some of Paladin Labs' revenue guidance. In the years that I checked, they beat the midpoint of their initial revenue guidance every year. Here are the relative guidance beats:
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Apr 01, 2023 7:23am
RE:RE:RE:RE:Remember back to Samira's last forecast ...
Yet the market spins higher and GUD continues to spin deep in the abbys.
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Mar 31, 2023 11:01pm
RE:RE:RE:Remember back to Samira's last forecast ...
Curousj ... you are right ... 8 years into Paladin's growth, they were over 70% gross margin. I don't think you're going to see that here - you're likely going to see it in the 50-60%
...more
(6)
•••
curiousj
X
View Profile
View Bullboard History
Comment by
curiousj
on Mar 31, 2023 3:11pm
RE:RE:Remember back to Samira's last forecast ...
What are your thoughts on ROI on current business? Especially, given how low GM% are if you compare to paladin who had >70%. Do you think mgmt will have to renegotiate contracts to make EBITDA
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Mar 31, 2023 7:01am
Mr mugsy and gudisbad
Two alias same person. According to mr mugsy he/she has been accumulating since the price was $10 bucks per share, 10 years ago. Question: Would anyone take financial advice from a person who has been
...more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Mar 31, 2023 4:33am
RE:Remember back to Samira's last forecast ...
Just a correction: the initial revenue guidance for 2022 was $260-$265M if I'm not mistaken? Midpoint was $262.5M compared to the $293.5M that we ended up with. 2022 included the $6M settlement
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Mar 30, 2023 11:14pm
Remember back to Samira's last forecast ...
Remember when Samira forecasted 2022 revenue? It was $250MM-$260MM. The forecast ended up creeping to $270MM and we hit over $290MM. Here we go with a fairly high initial revenue estimate and
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Mar 30, 2023 10:49pm
RE:RE:Annual Report & Annual Information Form Published
Does what make sense Wofat? I don't see a question except ... hurry up and wait? What are you asking to be validated? And if you want "validation," then you should ask Samira.
...more
(8)
•••
wofats
X
View Profile
View Bullboard History
Comment by
wofats
on Mar 30, 2023 8:58pm
RE:Annual Report & Annual Information Form Published
G2S2 Capital Inc. just added a bit over 800,000 shares to bring their holdings to over 12,000,000 shares.
(8)
•••
wofats
X
View Profile
View Bullboard History
Comment by
wofats
on Mar 30, 2023 7:40pm
RE:Annual Report & Annual Information Form Published
Does this make sense? I am looking for validation Not cheerleading . These additions will be complementing the regular business of the company for the first quarter. Most of them were added
...more
(8)
•••
hoffbag
X
View Profile
View Bullboard History
Post by
hoffbag
on Mar 30, 2023 7:36pm
People still look at this?
This was a dog 2 years ago when I looked at it. Still is but a cheaper one. Company still buying shares? May as well take it private.
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario